MENU

EVMN Evommune Inc. Forecast, Technical & Fundamental Analysis

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVMN is expected to report earnings to fall 12.36% to -77 cents per share on December 10

Evommune Inc. EVMN Stock Earnings Reports
Q3'26
Est.
$-0.78
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.12
The last earnings report on August 07 showed earnings per share of -88 cents, missing the estimate of -68 cents. With 648.13K shares outstanding, the current market capitalization sits at 304.49M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1841 Page Mill Road
Phone
+1 925 247-4481
Employees
48
Web
https://www.evommune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XLK197.812.06
+1.05%
State Street Technology Select Sector SPDR ETF (XLK)
SAGP34.97-0.02
-0.06%
Strategas Global Policy Opportunities ETF (SAGP)
SCUS25.04-0.07
-0.28%
Schwab Ultra-Short Income ETF (SCUS)
QEFA96.63-0.90
-0.92%
State Street SPDR MSCI EAFE StrategicFactors ETF (QEFA)
AAPB42.69-0.79
-1.83%
GraniteShares 2x Long AAPL Daily ETF (AAPB)